The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antipyretic Analgesics Market Research Report 2025
Synopsis
Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
The global Antipyretic Analgesics market was valued at US$ 2781.6 million in 2023 and is anticipated to reach US$ 3026.9 million by 2030, witnessing a CAGR of 1.2% during the forecast period 2024-2030.
From the perspective of product market application, adult antipyretic and analgesic drugs occupy the vast majority of product market application.
Antipyretic analgesic of the world's main producers have Mallinckrodt Pharmaceuticals, IOL, ruan pharmaceutical, Novacyl, basf, bbca pharmaceutical, hubei hundred Cohen di pharmaceutical co., LTD., xinhua pharmaceutical, Granules India Limited, changshu port of China, hebei JiHeng, zhejiang kangle pharmaceutical company, the professional medical technology co., LTD. Hebei province and hunan zhongnan pharmaceutical co., LTD., etc., together with the market share of around 60%.
This report aims to provide a comprehensive presentation of the global market for Antipyretic Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipyretic Analgesics.
Report Scope
The Antipyretic Analgesics market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antipyretic Analgesics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antipyretic Analgesics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF
Segment by Type
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others
Segment by Application
Adults
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antipyretic Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antipyretic Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
The global Antipyretic Analgesics market was valued at US$ 2781.6 million in 2023 and is anticipated to reach US$ 3026.9 million by 2030, witnessing a CAGR of 1.2% during the forecast period 2024-2030.
From the perspective of product market application, adult antipyretic and analgesic drugs occupy the vast majority of product market application.
Antipyretic analgesic of the world's main producers have Mallinckrodt Pharmaceuticals, IOL, ruan pharmaceutical, Novacyl, basf, bbca pharmaceutical, hubei hundred Cohen di pharmaceutical co., LTD., xinhua pharmaceutical, Granules India Limited, changshu port of China, hebei JiHeng, zhejiang kangle pharmaceutical company, the professional medical technology co., LTD. Hebei province and hunan zhongnan pharmaceutical co., LTD., etc., together with the market share of around 60%.
This report aims to provide a comprehensive presentation of the global market for Antipyretic Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipyretic Analgesics.
Report Scope
The Antipyretic Analgesics market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antipyretic Analgesics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antipyretic Analgesics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF
Segment by Type
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others
Segment by Application
Adults
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antipyretic Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antipyretic Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Antipyretic Analgesics Market Overview
1.1 Product Overview and Scope of Antipyretic Analgesics
1.2 Antipyretic Analgesics Segment by Type
1.2.1 Global Antipyretic Analgesics Market Value Comparison by Type (2024-2030)
1.2.2 Paracetamol
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Naproxen
1.2.6 Diclofenac
1.2.7 Oxaprozin
1.2.8 Dexibuprofen
1.2.9 Others
1.3 Antipyretic Analgesics Segment by Application
1.3.1 Global Antipyretic Analgesics Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Children
1.4 Global Antipyretic Analgesics Market Size Estimates and Forecasts
1.4.1 Global Antipyretic Analgesics Revenue 2019-2030
1.4.2 Global Antipyretic Analgesics Sales 2019-2030
1.4.3 Global Antipyretic Analgesics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antipyretic Analgesics Market Competition by Manufacturers
2.1 Global Antipyretic Analgesics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antipyretic Analgesics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antipyretic Analgesics Average Price by Manufacturers (2019-2024)
2.4 Global Antipyretic Analgesics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antipyretic Analgesics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antipyretic Analgesics, Product Type & Application
2.7 Antipyretic Analgesics Market Competitive Situation and Trends
2.7.1 Antipyretic Analgesics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antipyretic Analgesics Players Market Share by Revenue
2.7.3 Global Antipyretic Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antipyretic Analgesics Retrospective Market Scenario by Region
3.1 Global Antipyretic Analgesics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antipyretic Analgesics Global Antipyretic Analgesics Sales by Region: 2019-2030
3.2.1 Global Antipyretic Analgesics Sales by Region: 2019-2024
3.2.2 Global Antipyretic Analgesics Sales by Region: 2025-2030
3.3 Global Antipyretic Analgesics Global Antipyretic Analgesics Revenue by Region: 2019-2030
3.3.1 Global Antipyretic Analgesics Revenue by Region: 2019-2024
3.3.2 Global Antipyretic Analgesics Revenue by Region: 2025-2030
3.4 North America Antipyretic Analgesics Market Facts & Figures by Country
3.4.1 North America Antipyretic Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antipyretic Analgesics Sales by Country (2019-2030)
3.4.3 North America Antipyretic Analgesics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antipyretic Analgesics Market Facts & Figures by Country
3.5.1 Europe Antipyretic Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antipyretic Analgesics Sales by Country (2019-2030)
3.5.3 Europe Antipyretic Analgesics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antipyretic Analgesics Market Facts & Figures by Country
3.6.1 Asia Pacific Antipyretic Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antipyretic Analgesics Sales by Country (2019-2030)
3.6.3 Asia Pacific Antipyretic Analgesics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antipyretic Analgesics Market Facts & Figures by Country
3.7.1 Latin America Antipyretic Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antipyretic Analgesics Sales by Country (2019-2030)
3.7.3 Latin America Antipyretic Analgesics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antipyretic Analgesics Market Facts & Figures by Country
3.8.1 Middle East and Africa Antipyretic Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antipyretic Analgesics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antipyretic Analgesics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antipyretic Analgesics Sales by Type (2019-2030)
4.1.1 Global Antipyretic Analgesics Sales by Type (2019-2024)
4.1.2 Global Antipyretic Analgesics Sales by Type (2025-2030)
4.1.3 Global Antipyretic Analgesics Sales Market Share by Type (2019-2030)
4.2 Global Antipyretic Analgesics Revenue by Type (2019-2030)
4.2.1 Global Antipyretic Analgesics Revenue by Type (2019-2024)
4.2.2 Global Antipyretic Analgesics Revenue by Type (2025-2030)
4.2.3 Global Antipyretic Analgesics Revenue Market Share by Type (2019-2030)
4.3 Global Antipyretic Analgesics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antipyretic Analgesics Sales by Application (2019-2030)
5.1.1 Global Antipyretic Analgesics Sales by Application (2019-2024)
5.1.2 Global Antipyretic Analgesics Sales by Application (2025-2030)
5.1.3 Global Antipyretic Analgesics Sales Market Share by Application (2019-2030)
5.2 Global Antipyretic Analgesics Revenue by Application (2019-2030)
5.2.1 Global Antipyretic Analgesics Revenue by Application (2019-2024)
5.2.2 Global Antipyretic Analgesics Revenue by Application (2025-2030)
5.2.3 Global Antipyretic Analgesics Revenue Market Share by Application (2019-2030)
5.3 Global Antipyretic Analgesics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mallinckrodt Pharmaceuticals
6.1.1 Mallinckrodt Pharmaceuticals Corporation Information
6.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.1.3 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product Portfolio
6.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.2 IOL
6.2.1 IOL Corporation Information
6.2.2 IOL Description and Business Overview
6.2.3 IOL Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 IOL Antipyretic Analgesics Product Portfolio
6.2.5 IOL Recent Developments/Updates
6.3 Anqiu Lu'an Pharmaceutical
6.3.1 Anqiu Lu'an Pharmaceutical Corporation Information
6.3.2 Anqiu Lu'an Pharmaceutical Description and Business Overview
6.3.3 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product Portfolio
6.3.5 Anqiu Lu'an Pharmaceutical Recent Developments/Updates
6.4 Novacyl
6.4.1 Novacyl Corporation Information
6.4.2 Novacyl Description and Business Overview
6.4.3 Novacyl Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novacyl Antipyretic Analgesics Product Portfolio
6.4.5 Novacyl Recent Developments/Updates
6.5 BASF
6.5.1 BASF Corporation Information
6.5.2 BASF Description and Business Overview
6.5.3 BASF Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BASF Antipyretic Analgesics Product Portfolio
6.5.5 BASF Recent Developments/Updates
6.6 Anhui BBCA Pharmaceuticals
6.6.1 Anhui BBCA Pharmaceuticals Corporation Information
6.6.2 Anhui BBCA Pharmaceuticals Description and Business Overview
6.6.3 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product Portfolio
6.6.5 Anhui BBCA Pharmaceuticals Recent Developments/Updates
6.7 Hubei Biocause
6.6.1 Hubei Biocause Corporation Information
6.6.2 Hubei Biocause Description and Business Overview
6.6.3 Hubei Biocause Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hubei Biocause Antipyretic Analgesics Product Portfolio
6.7.5 Hubei Biocause Recent Developments/Updates
6.8 Xinhua Pharm
6.8.1 Xinhua Pharm Corporation Information
6.8.2 Xinhua Pharm Description and Business Overview
6.8.3 Xinhua Pharm Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Xinhua Pharm Antipyretic Analgesics Product Portfolio
6.8.5 Xinhua Pharm Recent Developments/Updates
6.9 Granules India Limited
6.9.1 Granules India Limited Corporation Information
6.9.2 Granules India Limited Description and Business Overview
6.9.3 Granules India Limited Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Granules India Limited Antipyretic Analgesics Product Portfolio
6.9.5 Granules India Limited Recent Developments/Updates
6.10 Huagang Pharm
6.10.1 Huagang Pharm Corporation Information
6.10.2 Huagang Pharm Description and Business Overview
6.10.3 Huagang Pharm Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Huagang Pharm Antipyretic Analgesics Product Portfolio
6.10.5 Huagang Pharm Recent Developments/Updates
6.11 Hebei Jiheng Pharmaceutical
6.11.1 Hebei Jiheng Pharmaceutical Corporation Information
6.11.2 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Description and Business Overview
6.11.3 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product Portfolio
6.11.5 Hebei Jiheng Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Kangle Pharmaceutical
6.12.1 Zhejiang Kangle Pharmaceutical Corporation Information
6.12.2 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Description and Business Overview
6.12.3 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product Portfolio
6.12.5 Zhejiang Kangle Pharmaceutical Recent Developments/Updates
6.13 Hebei Jingye Medical Technology
6.13.1 Hebei Jingye Medical Technology Corporation Information
6.13.2 Hebei Jingye Medical Technology Antipyretic Analgesics Description and Business Overview
6.13.3 Hebei Jingye Medical Technology Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hebei Jingye Medical Technology Antipyretic Analgesics Product Portfolio
6.13.5 Hebei Jingye Medical Technology Recent Developments/Updates
6.14 MSPF
6.14.1 MSPF Corporation Information
6.14.2 MSPF Antipyretic Analgesics Description and Business Overview
6.14.3 MSPF Antipyretic Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.14.4 MSPF Antipyretic Analgesics Product Portfolio
6.14.5 MSPF Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antipyretic Analgesics Industry Chain Analysis
7.2 Antipyretic Analgesics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antipyretic Analgesics Production Mode & Process
7.4 Antipyretic Analgesics Sales and Marketing
7.4.1 Antipyretic Analgesics Sales Channels
7.4.2 Antipyretic Analgesics Distributors
7.5 Antipyretic Analgesics Customers
8 Antipyretic Analgesics Market Dynamics
8.1 Antipyretic Analgesics Industry Trends
8.2 Antipyretic Analgesics Market Drivers
8.3 Antipyretic Analgesics Market Challenges
8.4 Antipyretic Analgesics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
